News

Developing gene therapies for rare diseases is one thing. Creating gene-edited “designer babies” is quite another. German legal expert Timo Minssen outlined the potentially explosive ethical landmines surrounding such issues during a recent talk at the New York Genome Center. Minssen directs the Center for Advanced Studies in…

Researchers recently reported the rare case of a 69-year-old Japanese man with paroxysmal atrial fribrillation (PAF) — occasional periods of an irregular, very fast heart rate — who developed hyperkalemia (high potassium levels in the blood) possibly due to cold agglutinin disease (CAD) after undergoing cryoballoon ablation…

A recent case report alerts clinicians to the fact that cold agglutinin disease (CAD) can arise as a complication of Pneumococcal vaccination. This is the first documented case of an adult who developed CAD associated with a specific self-reactive antibody (anti-Pr) following pneumococcal vaccination. The study, “Anti-Pr…

A rare type of cancer called histiocytic sarcoma may trigger the development of cold agglutinin hemolytic anemia, a recent case suggests. This malignant cancer, which arises from the transformation of some immune cells present in the connective tissue, should be considered as a secondary cause of cold agglutinin hemolytic…

A new international consortium based in Paris, and funded largely by the 28-member European Union, intends to speed the diagnosis of rare diseases, while also accelerating the development of treatments for the 95% of such illnesses that currently don’t have one. The European Joint Programme on Rare Diseases (EJP…